Wearing masks all day long can cause skin infection. Here is how you can deal with it

American biopharmaceutical company Gilead Sciences will soon start trials of an inhalable version of remdesivir, an antiviral drug that has shown promise as a therapeutic against the coronavirus in early trials, according to a statement released Monday.Remdesivir is currently given intravenously, which restricts its use to hospital settings. “That’s been the limitation” with this drug, […]

Continue Reading